These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20153792)

  • 1. Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica.
    Mendes RE; Pérez-Ecija RA; Zafra R; Buffoni L; Martínez-Moreno A; Dalton JP; Mulcahy G; Pérez J
    Vaccine; 2010 Apr; 28(16):2832-40. PubMed ID: 20153792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hepatic damage and local immune response in goats immunized with native glutathione S-transferase of Fasciola hepatica.
    Zafra R; Pérez-Ecija RA; Buffoni L; Mendes RE; Martínez-Moreno A; Martínez-Moreno FJ; Galisteo ME; Pérez J
    J Comp Pathol; 2010; 143(2-3):110-9. PubMed ID: 20185148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the liver of goats immunized with a synthetic peptide of the Sm14 antigen and challenged with Fasciola hepatica.
    Zafra R; Buffoni L; Martínez-Moreno A; Pérez-Ecija A; Martinez-Moreno FJ; Pérez J
    J Comp Pathol; 2008 Nov; 139(4):169-76. PubMed ID: 18768187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early hepatic and peritoneal changes and immune response in goats vaccinated with a recombinant glutathione transferase sigma class and challenged with Fasciola hepatica.
    Zafra R; Pérez-Écija RA; Buffoni L; Pacheco IL; Martínez-Moreno A; LaCourse EJ; Perally S; Brophy PM; Pérez J
    Res Vet Sci; 2013 Jun; 94(3):602-9. PubMed ID: 23261152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological and parasitological protection in goats immunised with recombinant cathepsin L1 and challenged with Fasciola hepatica.
    Pérez-Ecija RA; Mendes RE; Zafra R; Buffonni L; Martínez-Moreno A; Pérez J
    Vet J; 2010 Sep; 185(3):351-3. PubMed ID: 19665401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and late peritoneal and hepatic changes in goats immunized with recombinant cathepsin L1 and infected with Fasciola hepatica.
    Zafra R; Pérez-Écija RA; Buffoni L; Moreno P; Bautista MJ; Martínez-Moreno A; Mulcahy G; Dalton JP; Pérez J
    J Comp Pathol; 2013 May; 148(4):373-84. PubMed ID: 23083835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen.
    Mendes RE; Zafra R; Pérez-Ecija RA; Buffoni L; Martínez-Moreno A; Tendler M; Pérez J
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):698-705. PubMed ID: 20835620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response in goats immunised with cathepsin L1, peroxiredoxin and Sm14 antigen and experimentally challenged with Fasciola hepatica.
    Buffoni L; Martínez-Moreno FJ; Zafra R; Mendes RE; Pérez-Écija A; Sekiya M; Mulcahy G; Pérez J; Martínez-Moreno A
    Vet Parasitol; 2012 Apr; 185(2-4):315-21. PubMed ID: 22001704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the local immune response to Fasciola hepatica in the liver and hepatic lymph nodes of goats immunised with a peptide of the Sm14 antigen.
    Zafra R; Buffoni L; Pérez-Ecija RA; Mendes RE; Martínez-Moreno A; Martínez-Moreno FJ; Pérez J
    Res Vet Sci; 2009 Oct; 87(2):226-32. PubMed ID: 19345386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response of goats immunised with glutathione S-transferase and experimentally challenged with Fasciola hepatica.
    Buffoni L; Zafra R; Pérez-Ecija A; Martínez-Moreno FJ; Martínez-Galisteo E; Moreno T; Pérez J; Martínez-Moreno A
    Parasitol Int; 2010 Jun; 59(2):147-53. PubMed ID: 20035898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
    Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
    Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
    Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral response (IgG) of goats experimentally infected with Fasciola hepatica against cysteine proteinases of adult fluke.
    Ruiz A; Molina JM; González J; Martínez-Moreno FJ; Gutiérrez PN; Martínez-Moreno A
    Vet Res; 2003; 34(4):435-43. PubMed ID: 12911860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of Foxp3
    Escamilla A; Zafra R; Pérez J; McNeilly TN; Pacheco IL; Buffoni L; Martínez-Moreno FJ; Molina-Hernández V; Martínez-Moreno A
    Vet Parasitol; 2016 Oct; 230():14-19. PubMed ID: 27884436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats.
    Villa-Mancera A; Reynoso-Palomar A; Utrera-Quintana F; Carreón-Luna L
    Parasitol Res; 2014 Jan; 113(1):243-50. PubMed ID: 24218177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.